Failure of dabigatran following idarucizumab and omeprazole administration

被引：1

作者：

Mahawish, Karim M. ^{[1
]}

Leung, Almond ^{[1
]}

机构：

[1] MidCent DHB, Dept Internal Med, Palmerston North, New Zealand

来源：

INTERNAL MEDICINE JOURNAL | 2021年 / 51卷 / 01期

关键词：

THROMBIN TIME;

D O I：

10.1111/imj.15159

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：134 / 135

页数：2

共 50 条

[41] Idarucizumab for Dabigatran-Related Gastrointestinal Bleeds
Siegal, Deborah M.
Connolly, Stuart J.
CIRCULATION, 2019, 139 (06) : 757 - 759
[42] Idarucizumab for the treatment of dabigatran-related nephropathy
Alsamarrai, Ammar
Eaddy, Nicola
Curry, Elizabeth
CLINICAL KIDNEY JOURNAL, 2021, 14 (02) : 710 - 711
[43] Idarucizumab approved for reversal of anticoagulant effects of dabigatran
Traynor, Kate
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (23) : 2002 - +
[44] Idarucizumab (Praxbind) for Dabigatran (Pradaxa) Anticoagulant Reversal
Jarrett, Jennie B.
Gimbar, Renee Petzel
AMERICAN FAMILY PHYSICIAN, 2017, 95 (12) : 798 - 800
[45] Dabigatran-etexilate/omeprazole interactionDecreased anticoagulant effect following drug interaction led to treatment failure: case report
Reactions Weekly, 2021, 1865 (1) : 160 - 160
[46] Late rebound of dabigatran levels after idarucizumab reversal in two patients with severe renal failure
Stecher, Adela
Vene, Nina
Mavri, Alenka
Mijovski, Mojca Bozic
Krevel, Barbara
Gradisek, Primoz
EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2017, 34 (06) : 400 - 402
[47] Dabigatran etexilate/idarucizumab interactionParadoxical elevation of plasma dabigatran etexilate: case report
Reactions Weekly, 2018, 1725 (1) : 109 - 109
[48] Perioperative Myocardial Infarction Following Dabigatran Reversal With Idarucizumab in a Patient Undergoing Orthotopic Liver Transplantation
Barroso, Alex
Martinez-Gonzalez, M. Carmen
Knowlson, Nathanael
Miguel, Alba M.
Perez, Gonzalo
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
[49] Reversal of dabigatran with idarucizumab in hyperacute stroke: a new paradigm?
Ting, Amy
Venkat, Abhay R.
Gawarikar, Yash
Patel, Ronak
MEDICAL JOURNAL OF AUSTRALIA, 2019, 210 (07) : 302 - +
[50] Idarucizumab safe for reversal of dabigatran-induced anticoagulation
Reactions Weekly, 2015, 1558 (1) : 9 - 9

← 1 2 3 4 5 →